Study reveals surprising connection between common childhood virus CMV and Alzheimer's disease, offering new insights into prevention and treatment.

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) are two of the most valuable healthcare stocks in the world, largely due ...

Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease, ...

Researchers have linked herpes simplex virus-1 with Alzheimer's disease, revealing a surprising potential viral trigger for the neurodegenerative condition. Their study suggests that the tau protein, ...

A recent study by Tufts and Oxford universities reveals that head trauma can activate dormant herpes viruses in the brain, ...

The New Brunswick, N.J., pharmaceutical giant said posdinemab has shown potential in targeting disease-associated phosphorylated tau in cerebrospinal fluid from treated Alzheimer's patients, and in ...

Johnson & Johnson (NYSE: JNJ) announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to posdinemab, a phosphorylated tau-directed monoclonal antibody (mAb) ...

A new study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate groups and proposed an explanation for how cognitive impairment arises. The ...

POTOMAC, MD / ACCESSWIRE / January 8, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") announced today that its ongoing Phase 2 trial for agitation in Alzheimer's disease ...

ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today released ...

As Lamborn prepares to leave office, we are most grateful for his support. His support of these signed bills advances the ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...